We support COVID-19 (SARS-CoV-2) research and are operating in accordance to CDC and government guidelines. Learn about our anti-Human IgG, IgM & IgA antibodies.

Quickly detect multiple antigens in a single tissue section to gain clear understanding of the microenvironment without compromising samples. To serve your multiplex research needs, Bethyl introduces IHC PathPlex® panels to profile the complex tumor microenvironment. Each antibody has been validated for IHC and utilized in a multiplex format by our own scientists via proprietary processes to ensure the highest quality.

Learn More About PathPlex®

Reagents to Support your COVID-19 (SARS-CoV-2) Seroconversion Assay Development

With over 40 years of bulk affinity antibody production experience, Bethyl is your trusted partner for anti-Human IgG and IgM antibodies. Check out our Bulk Antibody Production Page. We can also partner with you to develop recombinant rabbit monoclonals against novel targets.

Learn More

Bringing the Tumor Microenvironment
into Focus

Simplified Development of Seven-Color Multiplex Immunohistochemistry-Immunofluorescence (mIF) Panels

With the advancement of immunotherapeutics, the need to understand the tumor microenvironment has never been more pressing. Recent advances in mIF and multispectral imaging facilitate accurate simultaneous analysis of multiple tissue markers.

Read More


Trial Sizes - Ideal for Comparisons & Application Testing

Trial sizes are ideal for comparisons between suppliers or various application testings and cost effective at $99 US. Over 6,000 trial-sized antibodies are available to more than 3,300 protein targets, and new releases are continuing to be added every month.

Find A Trial Size Now

Guarantee Statement

Bethyl's purpose is to improve lives by supporting scientific discovery. This drives our complete dedication to the highest standards of product and service quality.

Read More